Tianjin Tianyao Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Tianjin Tianyao Pharmaceuticals has a total shareholder equity of CN¥3.9B and total debt of CN¥772.5M, which brings its debt-to-equity ratio to 20%. Its total assets and total liabilities are CN¥6.0B and CN¥2.1B respectively. Tianjin Tianyao Pharmaceuticals's EBIT is CN¥232.6M making its interest coverage ratio 10.6. It has cash and short-term investments of CN¥818.4M.
Key information
20.0%
Debt to equity ratio
CN¥772.48m
Debt
| Interest coverage ratio | 10.6x |
| Cash | CN¥818.43m |
| Equity | CN¥3.86b |
| Total liabilities | CN¥2.13b |
| Total assets | CN¥5.99b |
Recent financial health updates
No updates
Recent updates
Tianjin Tianyao Pharmaceuticals (SHSE:600488) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Nov 05
Here's Why We Think Tianjin Tianyao Pharmaceuticals (SHSE:600488) Might Deserve Your Attention Today
Oct 28Tianjin Tianyao Pharmaceuticals' (SHSE:600488) Performance Is Even Better Than Its Earnings Suggest
Apr 04Financial Position Analysis
Short Term Liabilities: 600488's short term assets (CN¥2.1B) exceed its short term liabilities (CN¥1.4B).
Long Term Liabilities: 600488's short term assets (CN¥2.1B) exceed its long term liabilities (CN¥699.1M).
Debt to Equity History and Analysis
Debt Level: 600488 has more cash than its total debt.
Reducing Debt: 600488's debt to equity ratio has reduced from 24.7% to 20% over the past 5 years.
Debt Coverage: 600488's debt is well covered by operating cash flow (99.9%).
Interest Coverage: 600488's interest payments on its debt are well covered by EBIT (10.6x coverage).